v3.26.3
STATEMENTS OF CASH FLOWS - USD ($)
5 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:        
Net income $ (44,737) $ 881,113 $ 2,899,551 $ 5,926,421
Adjustments to reconcile net income to net cash used in operating activities:        
Interest income earned on investments held in Trust Account 0 (4,119,710) (1,733,912) (6,335,533)
Change in fair value of warrant liability     (1,435,682) 257,126
Changes in current assets and liabilities        
Prepaid Expenses (4,566) 8,996 (231,465) (131,268)
Deferred offering costs (125,665)   248,425 248,425
Accounts Payable   120,055    
Accrued Expenses   2,512,737 50,211 231,427
Accrued offering costs       (122,760)
Due to related party   (2,425) (121,358) 2,425
Net cash used in operating activities (174,968) (599,234) (324,230) (437,989)
Cash flows from investing activities:        
Investment of cash in Trust Account     (226,125,000) (226,125,000)
Net cash used in investing activities     (226,125,000) (226,125,000)
Cash flows from financing activities:        
Proceeds from the sale of Units     226,125,000 226,125,000
Proceeds from promissory note - related party 152,200   397,800 397,800
Payment of promissory note - related party     (550,000) (550,000)
Proceeds from sale of private placement warrants       6,968,750
Proceeds from sale of private placement warrants     7,568,750  
Proceeds from issuance of Class B ordinary shares 25,000      
Payment of underwriting fee     (4,500,000) (4,500,000)
Payment of offering costs     (1,624,662) (1,024,662)
Net cash provided by financing activities 177,200   227,416,888 227,416,888
Net change in cash 2,232 (599,234) 967,658 853,899
Cash, beginning of the period   856,131 2,232 2,232
Cash, end of the period 2,232 $ 256,897 969,890 856,131
Supplemental disclosure of cash flow information:        
Deferred underwriters' discount payable charged to additional paid-in capital     9,000,000  
Forfeiture of Class B ordinary shares     166,667  
Deferred offering costs included in accrued expenses     $ 1,402  
Deferred underwriters' discount payable       $ 9,000,000
Deferred offering costs included in accrued offering costs $ 122,760